$POAI
Predictive Oncology Inc. Stock $poai

$poai Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000117184321005844 Filed on August 11, 2021

Income Statement

Concept	2021 Q2	2020 Q2
Revenue	$350.2K	$182.8K
YoY Change	91.6%	-36.12%
Cost Of Revenue	$142.9K	$85.26K
YoY Change	67.58%	-27.98%
Gross Profit	$207.3K	$97.52K
YoY Change	112.6%	-41.87%
Gross Profit Margin	59.2%	53.35%
Selling, General & Admin	$2.238M	$3.345M
YoY Change	-33.1%	-16.28%
% of Gross Profit	1079.32%	3429.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$244.1K	$119.0K
YoY Change	105.14%	-9.47%
% of Gross Profit	117.72%	122.0%
Operating Expenses	$2.238M	$3.345M
YoY Change	-33.1%	-16.28%
Operating Profit	-$2.598M	-$3.768M
YoY Change	-31.05%	-26.09%
Interest Expense	-$30.91K	$870.0K
YoY Change	-103.55%	-85.88%
% of Operating Profit
Other Income/Expense, Net	$55.20K	-$680.0K
YoY Change	-108.12%	-17.0%
Pretax Income	-$2.574M	-$3.580M
YoY Change	-28.1%	-343.54%
Income Tax
% Of Pretax Income
Net Earnings	-$2.574M	-$3.577M
YoY Change	-28.05%	-344.17%
Net Earnings / Revenue	-734.97%	-1957.16%
Basic Earnings Per Share	-$0.05	-$0.36
Diluted Earnings Per Share	-$0.05	-$0.36
COMMON SHARES
Basic Shares Outstanding	51.58M	9.838M
Diluted Shares Outstanding	51.58M	9.838M

Balance Sheet

Concept	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$44.88M	$3.390M
YoY Change	1223.92%	4742.86%
Cash & Equivalents	$44.88M	$3.394M
Short-Term Investments
Other Short-Term Assets	$241.8K	$430.0K
YoY Change	-43.77%	186.67%
Inventory	$317.8K	$235.4K
Prepaid Expenses
Receivables	$196.5K	$272.5K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$45.64M	$4.329M
YoY Change	954.31%	295.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.951M	$2.410M
YoY Change	63.94%	36.16%
Goodwill	$2.814M	$15.69M
YoY Change	-82.07%	-34.05%
Intangibles	$3.255M	$3.540M
YoY Change	-8.04%	-22.92%
Long-Term Investments
YoY Change
Other Assets	$124.1K
YoY Change
Total Long-Term Assets	$11.28M	$23.17M
YoY Change	-51.33%	-25.64%
TOTAL ASSETS
Total Short-Term Assets	$45.64M	$4.329M
Total Long-Term Assets	$11.28M	$23.17M
Total Assets	$56.91M	$27.50M
YoY Change	106.98%	-14.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$942.0K	$2.449M
YoY Change	-61.54%	-30.8%
Accrued Expenses	$1.256M	$2.649M
YoY Change	-52.59%	155.83%
Deferred Revenue	$154.3K	$38.58K
YoY Change	300.04%	29.88%
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due		$5.467M
YoY Change
Total Short-Term Liabilities	$3.222M	$14.65M
YoY Change	-78.01%	54.95%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$47.15K	$98.36K
YoY Change	-52.07%	-80.33%
Total Long-Term Liabilities	$47.15K	$98.36K
YoY Change	-52.07%	-80.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.222M	$14.65M
Total Long-Term Liabilities	$47.15K	$98.36K
Total Liabilities	$3.824M	$15.81M
YoY Change	-75.8%	58.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$114.8M	-$90.61M
YoY Change	26.75%	39.53%
Common Stock	$653.4K	$131.9K
YoY Change	395.31%	-57.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$53.09M	$11.69M
YoY Change
Total Liabilities & Shareholders Equity	$56.91M	$27.50M
YoY Change	106.98%	-14.74%

Cashflow Statement

Concept	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$2.574M	-$3.577M
YoY Change	-28.05%	-344.17%
Depreciation, Depletion And Amortization	$244.1K	$119.0K
YoY Change	105.14%	-9.47%
Cash From Operating Activities	-$2.207M	-$3.750M
YoY Change	-41.15%	87.5%
INVESTING ACTIVITIES
Capital Expenditures	-$243.8K	-$10.00K
YoY Change	2337.8%	0.0%
Acquisitions
YoY Change
Other Investing Activities		$130.0K
YoY Change		160.0%
Cash From Investing Activities	-$243.8K	$120.0K
YoY Change	-303.15%	200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.02M	3.960M
YoY Change	405.64%	344.94%
NET CHANGE
Cash From Operating Activities	-2.207M	-3.750M
Cash From Investing Activities	-243.8K	120.0K
Cash From Financing Activities	20.02M	3.960M
Net Change In Cash	17.57M	330.0K
YoY Change	5225.06%	-130.84%
FREE CASH FLOW
Cash From Operating Activities	-$2.207M	-$3.750M
Capital Expenditures	-$243.8K	-$10.00K
Free Cash Flow	-$1.963M	-$3.740M
YoY Change	-47.51%	87.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	65402845
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	244830	USD
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65335159
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19804787
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44881034	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	678332	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	196520	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	256878	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	317826	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	289535	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	241799	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	289490	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	45637179	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1514235	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3950613	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3822700	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3254838	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3398101	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1131795	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1395351	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	124096	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	116257	USD
CY2021Q2	us-gaap	Goodwill Goodwill	2813792	USD
CY2020Q4	us-gaap	Goodwill Goodwill	2813792	USD
CY2021Q2	us-gaap	Assets Assets	56912313	USD
CY2020Q4	us-gaap	Assets Assets	13060436	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	941960	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1372070	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4431925	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1256087	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2588047	USD
CY2021Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	229620	USD
CY2020Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	521116	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1142608	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1069869	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	294382	USD
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	154345	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	53028	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	640353	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	597469	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3222365	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9336921	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	554716	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	845129	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	47146	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	235705	USD
CY2021Q2	us-gaap	Liabilities Liabilities	3824227	USD
CY2020Q4	us-gaap	Liabilities Liabilities	10417755	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	653352	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	198048	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167279695	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	110826949	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-114845753	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108383108	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	53088086	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2642681	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56912313	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13060436	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	350207	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	182784	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	630524	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	477727	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	142877	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	85261	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	240635	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	177918	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	207330	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	97523	USD
	us-gaap	Gross Profit GrossProfit	389889	USD
	us-gaap	Gross Profit GrossProfit	299809	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2077973	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3211817	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5348750	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6040293	USD
CY2021Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	567796	USD
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	159788	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	133015	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	274429	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	397424	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2598227	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3768425	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6375898	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7207777	USD
CY2021Q2	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	57033	USD
CY2020Q2	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	52965	USD
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	85292	USD
	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	52968	USD
CY2020Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	729837	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	236801	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1846912	USD
CY2021Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1829	USD
CY2021Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-30909	USD
CY2020Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-422081	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	64762	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-394974	USD
CY2021Q2	poai	Gain Loss On Receivable Previously Considered Uncollectable GainLossOnReceivablePreviouslyConsideredUncollectable	0	USD
CY2020Q2	poai	Gain Loss On Receivable Previously Considered Uncollectable GainLossOnReceivablePreviouslyConsideredUncollectable	1290000	USD
	poai	Gain Loss On Receivable Previously Considered Uncollectable GainLossOnReceivablePreviouslyConsideredUncollectable	0	USD
	poai	Gain Loss On Receivable Previously Considered Uncollectable GainLossOnReceivablePreviouslyConsideredUncollectable	1290000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2573932	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-3577378	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6462645	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8106695	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2573932	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3577378	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6462645	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8106695	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.10
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.10
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51581762
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9838152
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44089157
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7362240
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51581762
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9838152
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44089157
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7362240
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	2642681	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	143573	USD
CY2021Q1	poai	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	4495270	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	514011	USD
CY2021Q1	poai	Stock Issued During Period Value Issued For Services And Other Adjustments StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments	-4048	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	565082	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-3888713	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	35545087	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2021Q2	poai	Stock Issued During Period Value Inducement To Equity Line StockIssuedDuringPeriodValueInducementToEquityLine	588590	USD
CY2021Q2	poai	Stock Issued During Period Value Issued For Services And Other Adjustments StockIssuedDuringPeriodValueIssuedForServicesAndOtherAdjustments	48802	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33243	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2573932	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	53088086	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	11231318	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	130000	USD
CY2020Q1	poai	Stock Issued During Period Value Inducement To Promissory Note Extension StockIssuedDuringPeriodValueInducementToPromissoryNoteExtension	41250	USD
CY2020Q1	poai	Issuance Of Shares And Prefunded Warrants Pursuant To Private Placement Value IssuanceOfSharesAndPrefundedWarrantsPursuantToPrivatePlacementValue	457823	USD
CY2020Q1	poai	Stock Issued During Period Value Inducement To Convertible Debt StockIssuedDuringPeriodValueInducementToConvertibleDebt	120000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	116951	USD
CY2020Q1	poai	Stock Issued During Period Value Inducement To Equity Line StockIssuedDuringPeriodValueInducementToEquityLine	1869899	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	362300	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	287838	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-4529317	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	10355390	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	62373	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2192878	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	186300	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	35000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	134939	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-3577378	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	11691158	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6462645	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8106695	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	649126	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	402738	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	598325	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	422777	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	244830	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	858353	USD
	poai	Gain Losses On Debt Revaluation GainLossesOnDebtRevaluation	64762	USD
	poai	Gain Losses On Debt Revaluation GainLossesOnDebtRevaluation	-394974	USD
	poai	Debt Extinguishment Costs DebtExtinguishmentCosts	0	USD
	poai	Debt Extinguishment Costs DebtExtinguishmentCosts	300000	USD
	poai	Equity Instruments Issued Conversion Of Convertible Debt EquityInstrumentsIssuedConversionOfConvertibleDebt	-0	USD
	poai	Equity Instruments Issued Conversion Of Convertible Debt EquityInstrumentsIssuedConversionOfConvertibleDebt	-20695	USD
	poai	Equity Instruments Issued For Management And Consulting EquityInstrumentsIssuedForManagementAndConsulting	52471	USD
	poai	Equity Instruments Issued For Management And Consulting EquityInstrumentsIssuedForManagementAndConsulting	397300	USD
	poai	Gain Loss On Receivable Previously Considered Uncollectable GainLossOnReceivablePreviouslyConsideredUncollectable	-0	USD
	poai	Gain Loss On Receivable Previously Considered Uncollectable GainLossOnReceivablePreviouslyConsideredUncollectable	1290000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-118472	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-60358	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-113769	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28291	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	45212	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-39852	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	197182	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-430110	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-614651	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-198890	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	505380	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	101317	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1802	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-88559	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5526978	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6721084	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	610906	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	133850	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22870	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	43874	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-633776	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	89976	USD
	poai	Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts	50515810	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2761867	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	4495270	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1866554	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4162744	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	1459973	USD
	poai	Proceeds From Issuance Of Stock Pursuant To Equity Line ProceedsFromIssuanceOfStockPursuantToEquityLine	588590	USD
	poai	Proceeds From Issuance Of Stock Pursuant To Equity Line ProceedsFromIssuanceOfStockPursuantToEquityLine	1869899	USD
	poai	Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts	5057919	USD
	poai	Payments For Penalties PaymentsForPenalties	1073470	USD
	poai	Payments For Penalties PaymentsForPenalties	247327	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	25416	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	50363456	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9874355	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	44202702	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3243247	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	678332	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	150831	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44881034	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3394078	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	267328	USD
	poai	Stock Issued During Period Shares Exchange Agreement StockIssuedDuringPeriodSharesExchangeAgreement	0
	poai	Stock Issued During Period Shares Exchange Agreement StockIssuedDuringPeriodSharesExchangeAgreement	2322878
	poai	Stock Issued During Period Value Exchange Agreement Accrued Interest StockIssuedDuringPeriodValueExchangeAgreementAccruedInterest	143573	USD
	poai	Stock Issued During Period Value Exchange Agreement Accrued Interest StockIssuedDuringPeriodValueExchangeAgreementAccruedInterest	0	USD
	poai	Derivatives Debt Issued DerivativesDebtIssued	0	USD
	poai	Derivatives Debt Issued DerivativesDebtIssued	141463	USD
	us-gaap	Stock Issued1 StockIssued1	514011	USD
	us-gaap	Stock Issued1 StockIssued1	99305	USD
	poai	Inducement Shares Issued For Debt Extension InducementSharesIssuedForDebtExtension	0	USD
	poai	Inducement Shares Issued For Debt Extension InducementSharesIssuedForDebtExtension	41250	USD
	poai	Increase In Operating Lease Right Of Asset And Lease Liability Due To Lease Modification IncreaseInOperatingLeaseRightOfAssetAndLeaseLiabilityDueToLeaseModification	0	USD
	poai	Increase In Operating Lease Right Of Asset And Lease Liability Due To Lease Modification IncreaseInOperatingLeaseRightOfAssetAndLeaseLiabilityDueToLeaseModification	995571	USD
	poai	Warrants Issued Debt Issuance WarrantsIssuedDebtIssuance	0	USD
	poai	Warrants Issued Debt Issuance WarrantsIssuedDebtIssuance	179324	USD
	poai	Stock And Notes Issued StockAndNotesIssued	0	USD
	poai	Stock And Notes Issued StockAndNotesIssued	1492500	USD
	us-gaap	Interest Paid Net InterestPaidNet	694435	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44881034	USD
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2021Q1	poai	Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts	31077231	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Reclassifications</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain reclassifications have been made to the prior years’ condensed consolidated financial statements to conform to the current year presentation. The reclassifications had <em style="font: inherit;">no</em> effect on previously reported results of operations, cash flows or stockholders’ equity.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	12876498	USD
CY2021Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	196520	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	256878	USD
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	154345	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	53028	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	143322	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	191223	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Credit Risk</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high credit quality financial institutions and, by policy, generally limits the amount of credit exposure to any <em style="font: inherit;">one</em> financial institution. The Company has a credit risk of $119,857 for cash amounts held in a single institution that are in excess of amounts issued by the Federal Deposit Insurance Corporation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	119857	USD
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2021Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	197212	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	95898	USD
CY2021Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	86284	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	151366	USD
CY2021Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	34330	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	42271	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	317826	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	289535	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5765453	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5154547	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1814840	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1331847	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3950613	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3822700	USD
	us-gaap	Depreciation Depreciation	482993	USD
	us-gaap	Depreciation Depreciation	249049	USD
CY2021Q2	us-gaap	Depreciation Depreciation	244062	USD
CY2020Q2	us-gaap	Depreciation Depreciation	118974	USD
CY2021Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4149291	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	894453	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3254838	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4126421	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	728320	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3398101	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	166133	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	153689	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	83086	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	77184	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	220993	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	183910	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	183910	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	183910	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	249182	USD
CY2021Q2	poai	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	2232933	USD
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3254838	USD
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	0	USD
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	4676755	USD
CY2021Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	-0	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	244830	USD
CY2021Q2	us-gaap	Notes Payable NotesPayable	0	USD
CY2020Q4	us-gaap	Notes Payable NotesPayable	4431925	USD
CY2021Q1	poai	Sale Of Stock Agent Placement Fee Percent Of Gross Proceeds SaleOfStockAgentPlacementFeePercentOfGrossProceeds	0.075	pure
CY2021Q1	poai	Sale Of Stock Management Fee Percent Of Gross Proceeds SaleOfStockManagementFeePercentOfGrossProceeds	0.01	pure
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	22531864
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	34396319	USD
CY2021Q1	poai	Proceeds From Issuance Or Sale Of Equity Net Of Stock Issuance Costs ProceedsFromIssuanceOrSaleOfEquityNetOfStockIssuanceCosts	31077231	USD
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33243	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	134939	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	598325	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	422777	USD
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	41402	USD
CY2019Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	50989	USD
CY2020Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	27107	USD
CY2020Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	2814798	USD
CY2020Q2	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	1701756	USD
CY2020Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-422081	USD
CY2020Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	4629570	USD
CY2020Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	294382	USD
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	95671	USD
CY2021Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	198711	USD
CY2021Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-30909	USD
CY2021Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	229620	USD
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2573932	USD
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3577378	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6462645	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8106695	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51581762
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9838152
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44089157
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7362240
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2020Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51581762
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9838152
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44089157
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7362240
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.10
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.10
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	350207	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	182784	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	630524	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	477727	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2573932	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-3577378	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6462645	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8106695	USD
CY2021Q2	us-gaap	Assets Assets	56912313	USD
CY2020Q4	us-gaap	Assets Assets	13060436	USD

Files In Submission

Name	View Source	Status
0001171843-21-005844-index-headers.html	Edgar Link	pending
0001171843-21-005844-index.html	Edgar Link	pending
0001171843-21-005844.txt	Edgar Link	pending
0001171843-21-005844-xbrl.zip	Edgar Link	pending
ex_274410.htm	Edgar Link	pending
ex_274411.htm	Edgar Link	pending
ex_274412.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
poai-20210630.xsd	Edgar Link	pending
poai-20210630_cal.xml	Edgar Link	unprocessable
poai-20210630_def.xml	Edgar Link	unprocessable
poai-20210630_lab.xml	Edgar Link	unprocessable
poai-20210630_pre.xml	Edgar Link	unprocessable
poai20210630_10q.htm	Edgar Link	pending
poai20210630_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POAI
Predictive Oncology Inc. Stock $poai

2021 Q2 Form 10-Q Financial Statement

#000117184321005844 Filed on August 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POAI Predictive Oncology Inc. Stock $poai

2021 Q2 Form 10-Q Financial Statement

#000117184321005844 Filed on August 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POAI
Predictive Oncology Inc. Stock $poai